ching tai huang - Infectious Diseases

Author Information

Ching-Tai Huang is a distinguished researcher affiliated with the Division of Infectious Diseases, Department of Internal Medicine at Chang Gung Memorial Hospital, Linkou, part of Chang Gung University College of Medicine in Taoyuan, Taiwan. His research primarily focuses on infectious diseases, with significant contributions to understanding bacterial coinfections, antimicrobial resistance, and vaccine safety and immunogenicity.

Research Contributions

Dr. Huang's research encompasses a broad range of topics within infectious diseases. Notable contributions include studies on the interaction between Streptococcus pneumoniae and influenza A virus, investigations into the safety and immunogenicity of SARS-CoV-2 vaccines in HIV-infected individuals, and the prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus among HIV patients in Taiwan. His work also addresses the antimicrobial resistance profiles of bacterial pathogens, such as carbapenem-resistant Klebsiella pneumoniae, and the effectiveness of treatments like remdesivir for SARS-CoV-2 infections.

Aliases

Ching-Tai Huang is also known in some publications and professional circles as Ching Tai Huang.

Publication and Citation Metrics

Metric	Value
Total Number of Papers	54
Total Citation Count	1259
H-index	19

Publications:

Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus

DOI: 10.1186/s12929-021-00756-0

Year: 2021

Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV

DOI: 10.1101/2021.12.08.21267439

Year: 2021

Methicillin-resistant Staphylococcus aureus nasal colonization among HIV-infected patients in Taiwan: prevalence, molecular characteristics and associated factors with nasal carriage

DOI: 10.1186/s12879-020-04979-8

Year: 2020

Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii

DOI: 10.1080/22221751.2020.1822757

Year: 2020

Methicillin-resistant Staphylococcus aureus nasal colonization among HIV-infected patients in Taiwan: prevalence, molecular characteristics and associated factors with nasal carriage

DOI: 10.21203/rs.2.18964/v2

Year: 2020

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

DOI: 10.1016/j.ijantimicag.2020.105933

Year: 2020

Methicillin-resistant Staphylococcus aureus nasal colonization among HIV-infected patients in Taiwan: prevalence, molecular characteristics and associated factors with nasal carriage

DOI: 10.21203/rs.2.18964/v3

Year: 2020

The antimicrobial susceptibility in adult invasive pneumococcal disease in the era of pneumococcus vaccination: A hospital-based observational study in Taiwan.

DOI: 10.1016/j.jmii.2020.01.003

Year: 2020

Reply to Zhou and Wu, “Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam”

DOI: 10.1128/AAC.02028-19

Year: 2020

Does Antimicrobial Therapy Affect Mortality of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria? A Nationwide Multicenter Study in Taiwan

DOI: 10.3390/microorganisms8122035

Year: 2020

Are There Any Vaccines for Malaria?

How are Structural Proteins Studied?

How Can Education Help in the Prevention of Infectious Diseases?

How Do Pathogens Invade Hosts?

How Do Antimicrobials Work?

How is HTS Applied in Infectious Diseases?

How Does the CDC Respond to Emerging Infectious Diseases?

How Do Antivirals Work?

How to Interpret Chest CT Scan Results?

What are Antiparasitics?

Partnered Content Networks

Relevant Topics